Adrenergic Agonists Prof. A. Alhaider. Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC.

Slides:



Advertisements
Similar presentations
Sympathetic Drugs. Stress and The Adrenal Glands.
Advertisements

PHARMACOLOGY OF SNS.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
Pharmacology-1 PHL 211 Fourteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
SYMPATHOMIMETIC DRUGS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode.
ADRENERGIC ANTAGONITS
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
1.  It is the major constituent of the adrenal medulla secretion (80%).  Hydrochloride aqueous solutions are hydrolyzed rapidly in alkaline or neutral.
Autonomic Nervous System
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics- Ph d Mahatma Gandhi Medical college and research institute, puducherry,
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic Agonists (Sympathomimetics)
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors  Alpha-(α-) adrenergic receptors,
Sympathomimetics (continue)
SYMPATHOMIMETIC DRUGS
Adrenergic agonists Samuel Aguazim (MD).
AUTONOMIC SYSTEMS AND DRUGS-2
Adrenergic preparations
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
1 A N S  NERVOUS SYSTEM  PNS CNS   EFFERENT AFFERENT   ANS SOMATIC  ENTERIC  PARASYMPATHETIC  SYMPATHETIC.
Sympathetic Nervous System Needed for studying SNS PHARMACOLOGY
 Differ in: Site of ganglia Length of pre & postganglionic fiber Mediators of postganglionic fiber Ramifies adrenal medulla and its mediator circulate.
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Adrenergic & Antiadrenergic Drugs By Prof. Alhaider.
Adrenoceptor activating & Other Sympathomimetic drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Sympathomimetic Agents
Sympathetic Nervous System Needed for studying SNS PHARMACOLOGY
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Actions of epinephrine:
Lecture 11b Clinical uses of adrenergic agonists.
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
SYMPATHOMIMETIC AGENTS
Adrenergic Drugs.
Adrenergic Agonists.
Sympatholytic & adrenergic blockers -receptor Antagonists
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
على قدر الهدف يكون الانطلاق.
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Antimuscarinic Agents
Adrenergic agonist: PHARMACOLOGY OF SNS.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic drugs.
Pharmacological actions of cathecholamines
Sympathomimetics Domina Petric, MD.
School of Pharmacy, University of Nizwa
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic agonists and antagonists
Adrenergic System And Drugs  Adrenergic transmission  Adrenergic receptor  Adrenergic drugs  Therapeutic classification of adrenergic drugs  Pharmacological.
SNS Drugs Anita Bolina 23rd March 2019.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic agonists ILOS
Adrenergic Agonists.
Presentation transcript:

Adrenergic Agonists Prof. A. Alhaider

Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC SYMPATHETIC NERVE ENDING NE  E Dopamine (DA) E ADRENAL MEDULLA

Adrenergic Receptors  - Adrenoceptors:  1 - Adrenoceptors: at blood vessels (if stimulated lead to vasoconstriction and increase in Blood Pressure and decongestion.  2 -adrenoceptors: at presynaptic cleft and some time called autoreceptors. Stimulation of these receptors inhibit the release of NE thus leading to antihypertensive action.

2)  -adrenoceptors  1-adrenoceptors: present mainly in the heart (A.S and A.V nodes and at myocites) Stimulation of these receptors leads to an increase in heart rate (positive chronotropic effect) and increase in contractility (positive iontropic effect)  2-adrenoceptors: present in bronchioles, skeletal blood vessels and uterus. Stimulation of which gives rise to bronchodilation and vasodilation of blood vessels and relaxation of uterus (Uterine Relaxant)

Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode of action Alpha & beta- adrenergic receptor blockers

According to spectrum of action; Non-Selective Norepinephrine, epinephrine, dopamine, isoprenaline, ephedrine,…etc Selective (at  or  )  1 ; Phenylephrine  2 ; Clonidine  1 ; Dobutamine  2 ; Salbutamol According to chemistry; Catecholamines; Natural; NE, E, Dopamine Synthetic; Isoprenaline Rapidly acting / Degraded by MOA & COMT Sparse CNS effects / Parenterally administered Non-Catecholamines; Ephedrine Delayed action / Resist degradation by MOA Prominant CNS effects / Orally administered ADRENERGIC STIMULANTS

According to mode of action; Direct; Stimulate adrenergic receptors directly. e.g. adrenaline, noraderanaline, dopamine, isoprenaline, phenylephrine, methoxamine, naphazoline, clonidine, dobutamine, salbutamol….etc Indirect; Release of NE from presynaptic stores at adrenergic nerve terminals e.g. amphetamine Or Inhibit uptake  its availability in synapse. e.g. Cocaine & antidepressants Dual; Direct and indirect stimulation of adrenergic receptors e.g. ephedrine, pseudoephedrine

ADRENERGIC STIMULANTS DIRECT Acting Sympathomimetics ADRENALINE Naturally released from adrenal medulla  2 ndry to stress, hunger, fear Inactivated by intestinal enzymes, so given parentral & by inhalation Acts on all ADR;  =/>  Pharmacological actions see physiological actions of the SNS Heart  + inotropic, chronotropic, dromotropic & lusiotropic ( excitability)(    BP  systolic (    / diastolic   low dose (    &  high dose (    Vascular SMC; constrict skin + peripheral (    dilate coronary +skeletal (    Non vascular SMC; Lung  bronchiodilatation (    GIT   motility (    / contract sphincter (    Bladder   detrusor m. (    / contract trigone & sphincter (    Pregnant uterus  tocolytic (    Eye  mydriasis (    /  no effect on accommodation or intraocular P Metabolism  insulin (   , glucagon (    liver glycogenolysis + sk. m. glycolysis (    /  adipose lipolysis (      CNS  little, headache, tremors & restlessness

Used locally; as haemostatic (in epistaxsis) with local anesthetics   its absorption  toxicity & prolong action +  bleeding from incision Used systemically for treatment of Allergic reactions  drug of choice in anaphylactic shock as it is the physiological antagonist of histamine Also in urticaria, angioneurotic edema & other hypersensitivity reactions due to  BP & cause vasoconstricton In status asthmatics  given parentally  bronchodilatation (  2 ) +   mucosal edema (  1 ) N.B. Selective  2 are better in asthma by inhalation In cardiac arrest  direct but now through central line N.B. Selective  1 are better ADRENALINE Indications

ADRs ADRENALINE Tachycardia, palpitation, arrhythmias, angina pains Headache, weakness, tremors anxiety and restlessness. Hypertension  cerebral hemorrhage and pulmonary edema. Coldness of extremities  tissue necrosis and gangrene if extravasation Nasal stuffiness; rebound congestion if used as decongestion Contraindications CHD, hypertension, peripheral arterial disease. Hyperthyroidism. Closed-angle glaucoma  may IOP

Direct Acting Sympathomimetics NOREPINEPHRINE = NORADRENALINE It is naturally released from postganglionic adrenergic fibres Not used much therapeutically  severe vasoconstriction Acts on  >  1 (but has no effect on  2 ) Only administered IV - Not IM or Subcutaneous  necrosis It BP [ systolic & diastolic]  reflex bradycardia (vagal stimulation)  CO not much changed Used systemically; hypotensive states ( in spinal anesthesia, in septic shock, if fluid replacement and inotropics fail) !!! Used topically; as a local haemostatic with local anesthetic !? ADRENERGIC STIMULANTS Indications

Direct Acting Sympathomimetics DOPAMINE ADRENERGIC STIMULANTS Vessels  1 Kidney D 1 vasodilatation + diuresis Heart  1 force ISOPRENALINE It is synthetic ; show no presynaptic uptake nor breakdown by MOA  longer action. Acts on  >  >  10 times > broncho-dilatation  Was used by inhalation in acute asthma Used in cardiac arrest but contraindicated in hyperthyroidism & congestive heart failure [CHD] It is a natural CNS transmitter. Released from postganglionic adrenergic fibres (> renal vessels) Releases NE from postganglionic adrenergic fibres Acts on D 1 >  1 >  1

Direct Acting Sympathomimetics ADRENERGIC STIMULANTS It is the drug of choice in treatment of SHOCK  septic, hypovolaemic (after fluid replacement), cardiogenic It BP & CO (   ), without causing renal impairment (D 1 ) Can be given in acute heart failure (HF) but better dobutamine Given parentrally by infusion On heart  Inotropic, no chronotropic effect On BP  According to dose; first  D 1 then due to  1 followed by  1 effect Indications DOPAMINE

Direct Acting Sympathomimetics ADRENERGIC STIMULANTS DOBUTAMINE It is synthetic. Given IV. Why? Acts mainly on  1 and very week on  2 >  1 On heart  Inotropic with little chronotropic effect On BP  No or little  in therapeutic dose no action at  1 ) Given parentrally by infusion for short term management of cardiac decompensation after cardiac surgery, in acute heart failure [AHF]: It is preferred because it does not oxygen demand Indications

Direct Acting Sympathomimetics PHENYLPHERINE ADRENERGIC STIMULANTS It is synthetic, noncatecholamine therefore can be given orally & has prolonged duration of action. Acts as selective  1 Systemically; Pressor agent in hypotensive states. Infusion Terminate atrial tachycardia (reflex bradycardia)????? Nasal decongestant. Oral Topically; Local Haemostatic, with Local anesthesia. Decongestant ( nasal & ocular) Mydriatic (no cycloplegia) Peaks in 20 min. t ½ 30 min. In Hypotension MIDODRINE On heart  reflex bradycardia On BP  due to vasoconstriction (  1 ) Indications

Direct Acting Sympathomimetics ADRENERGIC STIMULANTS IMIDAZOLINE PHENYLETHYLAMINES Phenylephrine Methoxamine Naphazoline Oxymetazoline HCI (Afrin) Xylometazoline HCI (Otrivine) Nasal & Ocular Decongestants CLONIDINE It is synthetic, imidazoline Given orally or as patch. Acts selectively on presynaptic  2 & on Imidazoline Receptors  BP  by action on (  2 ) at nucleus tractus solitarius to  sympathetic outflow to heart & vessels.  Antihypertensive agent N.B. Brimonidine is an imidazoline   2 agonist used in glucoma Used for treatment of nasal stuffiness But can cause Rebound nasal stuffiness Pseudoephedrine

Direct Acting Sympathomimetics ADRENERGIC STIMULANTS SALBUTAMOL It is synthetic. Given orally or parentral but mainly by inhalation Acts selectively on  2  on bronchi. Hardly effect on heart (   ) Bronchodilater  asthma & chronic obstructive airway disease (COPD) N.B. Because t 1/2 is 4 hrs longer acting preparations exist ; Salmeterol & Formoterol Other selective  2 agonists : Terbutaline; Bronchodilator & Tocolytic Ritodrine; Tocolytic  postpone premature labour (labour that begins before the 37 th week of gestation).

ADRENERGIC STIMULANTS INDIRECT Acting Sympathomimetics AMPHETAMINE It acts indirectly; Releasing NE from adrenergic nerve endings > Blocking of its reuptake Because it depletes vesicles from stored NE  tachyphylaxsis???  Weight   appetite increase energy expenditure Absorbed orally, not destroyed by MAO, excreted mostly unchanged ( by acidification of urine) No more used therapeutically  induces psychic & physical dependence and psychosis + the CVS side effects Acts on  &   similar to norepinephrine but has CNS stimulant effects; mental alertness, wakefulness, concentration & self-confidence / followed by depression & fatigue on continued use euphoria  causes its abuse…..

ADRENERGIC STIMULANTS DUAL Acting Sympathomimetics EPHEDRINE Plant alkaloid, synthetic, mixed sympathomimetic; Prolonged direct action on receptors  receptor down regulation Release NE from adrenergic nerve endings  depletes stores  tachyphylaxsis Acts on  &  + > facilitation of neuromuscular transmission & retention of urine + has CNS stimulant effects (less than amphetamine) Absorbed orally, not destroyed by MAO or COMT  prolonged action No more therapeutically used  but is abused by athletes and prohibited during games. Pseudoephedrine, dual acting < CNS & pressor effects compared to ephedrine. Used as nasal & ocular decongestant & in flue remedies. Abuse in Athletes

Agents specifically indicated for hypotension Midodrine, Phenylephrine, Norepinephrine, Phenylpropanolamine Agents specifically indicated for cardiogenic shock  AHF Dobutamine, Dopamine, Epinephrine Agents specifically indicated for shock Dopamine, Norepinephrine Agents specifically indicated for cardiac arrest Dobutamine, Epinephrine, Norepinephrine Agents specifically indicated for bronchial asthma Salbutamol, Salmeterol, Formoterol, Terbutaline Agents specifically indicated for premature labour Ritodrine, Terbutaline Agents specifically indicated for nasal decongestion Pseudoephedrine, Naphazoline, Oxymetazoline, Phenylephrine, Xylometazoline Agents specifically abused in sports  Ephedrine, Amphetamine